Condensed Financial Information of the Parent Company (Tables)

6 Months Ended

12 Months Ended

Apr. 30, 2026

Oct. 31, 2025

Condensed Financial Information of the Parent Company [Abstract]

Schedule of Condensed Balance Sheet

CONDENSED BALANCE SHEET

		April 30, 2026				October 31, 2025
		US$				US$
ASSETS
Current assets
Cash and cash equivalents			289				291
Other receivable			4,961				5,004
Total current assets			5,250				5,295
Investment in unconsolidated subsidiaries			13,599,059				12,481,495
Total assets			13,604,309				12,486,790
LIABILITIES
Current liabilities
Other payables			178,476				180,000
Due to related parties			52,239				23,003
Contract liability			198,528				-
Total current liabilities			429,243				203,003
Total liabilities			429,243				203,003
Total shareholders’ equity			13,175,066				12,283,787
Total liabilities and shareholders’ equity			13,604,309				12,486,790

CONDENSED BALANCE SHEET

		October 31, 2025				October 31, 2024
		US$				US$
ASSETS
Current assets
Cash and cash equivalents			291				-
Other receivable			5,004				-
Total current assets			5,295				-
Investment in unconsolidated subsidiaries			12,481,495				7,953,227
Total assets			12,486,790				7,953,227
LIABILITIES
Current liabilities
Other payables			180,000				-
Due to related parties			23,003
Total current liabilities			203,003				-
Total liabilities			203,003				-
Total shareholders’ equity			12,283,787				7,953,227
Total liabilities and shareholders’ equity			12,486,790				7,953,227

Schedule of Condensed Statement of Income and Comprehensive Income

CONDENSED STATEMENT OF INCOME AND COMPREHENSIVE INCOME

		For The Six Months Ended April 30,
		2026				2025
		US$				US$
Revenues			—				—
Operating expenses
General and administrative			—				—
Loss from operations			—				—
Equity method income			610,432				165,925
Interest expense			—				—
Income before income taxes			610,432				165,925
Income tax expense			—				—
Net income			610,432				165,925
Other comprehensive income/(loss)
Foreign currency translation difference			280,847				(108,280	)
Total comprehensive income			891,279				57,645

CONDENSED STATEMENT OF INCOME AND COMPREHENSIVE INCOME

		October 31, 2025				October 31, 2024				October 31, 2023
		US$				US$				US$
Revenues			—				—				—
Operating expenses
General and administrative			(200,463	)			—				—
Loss from operations			(200,463	)			—				—
Equity method income			200,527				1,813,170				1,909,271
Interest expense			1,962				—				—
Income before income taxes			2,026				1,813,170				1,909,271
Income tax expense			—				—				—
Net income			2,026				1,813,170				1,909,271
Other comprehensive loss
Foreign currency translation difference			52,666				36,714				(39,443	)
Total comprehensive income			54,692				1,849,884				1,869,828

Schedule of Condensed Statement of Cash Flows

CONDENSED STATEMENT OF CASH FLOWS

		For The Six Months Ended April 30,
		2026				2025
		US$				US$
Cash Flows from Operating Activities:
Net income			610,432				165,925
Foreign exchange (gain) loss			(1,479	)
Equity method income			(836,717	)			(165,925	)
Advances from customers			198,528				-
Due to related parties			29,236				-
Net cash used in operating activities			-				-
Investments in subsidiary			-				-
Net cash provided by investing activities			-				-
Proceeds from issuance of common stock			-				-
Net cash provided by financing activities			-				-
Net decrease in cash and cash equivalents			-				-
Cash and cash equivalents, beginning of year			291				-
Effect of exchange rate changes on cash and cash equivalents			(2	)			-
Cash and cash equivalents, end of year			289				-

CONDENSED STATEMENT OF CASH FLOWS

		October 31, 2025				October 31, 2024				October 31, 2023
		US$				US$				US$
Cash Flows from Operating Activities:
Net income			2,026				1,813,170				1,909,271
Equity method income			(253,193	)			(1,849,884	)			(1,869,828	)
Other receivables			(5,004	)			-				-
Other payables			180,000				-				-
Due to related parties			23,003				-				-
Net cash used in operating activities			(53,168	)			(36,714	)			39,443
Investments in subsidiary			(4,275,075	)			(787,266	)			-
Net cash provided by investing activities			(4,275,075	)			(787,266	)			-
Proceeds from issuance of common stock			4,275,868				787,266				-
Net cash provided by financing activities			4,275,868				787,266				-
Net decrease in cash and cash equivalents			(52,375	)			(36,714	)			39,443
Cash and cash equivalents, beginning of year			-				-				-
Effect of exchange rate changes on cash and cash equivalents			52,666				36,714				(39,443	)
Cash and cash equivalents, end of year			291				-				-